Portal de Periódicos da CAPES

MicroRNA-143 (miR-143) Regulates Cancer Glycolysis via Targeting Hexokinase 2 Gene

2012; Elsevier BV; Volume: 287; Issue: 27 Linguagem: Inglês

10.1074/jbc.m112.373084

1083-351X

Rong Fang, Tian Xiao, Zhaoyuan Fang, Yihua Sun, Fei Li, Yijun Gao, Yan Feng, Li Li, Ye Wang, Xiaolong Liu, Haiquan Chen, Xin‐Yuan Liu, Hongbin Ji,

Cancer, Hypoxia, and Metabolism

High glycolysis, well known as “Warburg effect,” is frequently observed in a variety of cancers. Whether the deregulation of miRNAs contributes to the Warburg effect remains largely unknown. Because miRNA regulates gene expression at both mRNA and protein levels, we constructed a gene functional association network, which allows us to detect the gene activity instead of gene expression, to integratively analyze the microarray data for gene expression and miRNA expression profiling and identify glycolysis-related gene-miRNA pairs deregulated in cancer. Hexokinase 2 (HK2), coding for the first rate-limiting enzyme of glycolysis, is among the top list of genes predicted and potentially regulated by multiple miRNAs including miR-143. Interestingly, miR-143 expression was inversely associated with HK2 protein level but not mRNA level in human lung cancer samples. miR-143, down-regulated by mammalian target of rapamycin activation, reduces glucose metabolism and inhibits cancer cell proliferation and tumor formation through targeting HK2. Collectively, we have not only established a novel methodology for gene-miRNA pair prediction but also identified miR-143 as an essential regulator of cancer glycolysis via targeting HK2.Background: Hexokinase 2 (HK2) is frequently overexpressed in malignant tumors.Results: miR-143 down-regulates HK2 and inhibits glucose metabolism and cancer progression.Conclusion: miR-143 is an essential regulator of cancer glycolysis via targeting HK2.Significance: Discovering the important role of miRNA in cancer metabolism may provide potential targets for cancer therapy. High glycolysis, well known as “Warburg effect,” is frequently observed in a variety of cancers. Whether the deregulation of miRNAs contributes to the Warburg effect remains largely unknown. Because miRNA regulates gene expression at both mRNA and protein levels, we constructed a gene functional association network, which allows us to detect the gene activity instead of gene expression, to integratively analyze the microarray data for gene expression and miRNA expression profiling and identify glycolysis-related gene-miRNA pairs deregulated in cancer. Hexokinase 2 (HK2), coding for the first rate-limiting enzyme of glycolysis, is among the top list of genes predicted and potentially regulated by multiple miRNAs including miR-143. Interestingly, miR-143 expression was inversely associated with HK2 protein level but not mRNA level in human lung cancer samples. miR-143, down-regulated by mammalian target of rapamycin activation, reduces glucose metabolism and inhibits cancer cell proliferation and tumor formation through targeting HK2. Collectively, we have not only established a novel methodology for gene-miRNA pair prediction but also identified miR-143 as an essential regulator of cancer glycolysis via targeting HK2. Background: Hexokinase 2 (HK2) is frequently overexpressed in malignant tumors. Results: miR-143 down-regulates HK2 and inhibits glucose metabolism and cancer progression. Conclusion: miR-143 is an essential regulator of cancer glycolysis via targeting HK2. Significance: Discovering the important role of miRNA in cancer metabolism may provide potential targets for cancer therapy.